KinCon biolabs develops live-cell biosensors to measure protein activity in cells. Their technology tracks changes in protein shape caused by drugs under physiological conditions. It integrates patient-specific mutations into biosensors to test how drugs work on these variants. The company supports drug development, especially for diseases involving mutated enzymes.
Something missing or incorrect on this page? Help us enrich this information
